Antonia Castilho
Overview
Explore the profile of Antonia Castilho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
587
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee T, Castilho A, Cheung V, Tang K, Ma S, Ng I
Cell Stem Cell
. 2011 Jul;
9(1):50-63.
PMID: 21726833
Tumor-initiating cells (T-ICs) are a subpopulation of chemoresistant tumor cells that have been shown to cause tumor recurrence upon chemotherapy. Identification of T-ICs and their related pathways are therefore priorities...
2.
Ma S, Tang K, Chan Y, Lee T, Kwan P, Castilho A, et al.
Cell Stem Cell
. 2010 Nov;
7(6):694-707.
PMID: 21112564
A novel paradigm in tumor biology suggests that cancer growth is driven by stem-like cells within a tumor, called tumor-initiating cells (TICs) or cancer stem cells (CSCs). Here we describe...
3.
Lee T, Castilho A, Cheung V, Tang K, Ma S, Ng I
Hepatology
. 2010 Oct;
53(1):160-70.
PMID: 20979057
Unlabelled: Liver tumor-initiating cells (T-ICs) are capable of self-renewal and tumor initiation and are more chemoresistant to chemotherapeutic drugs. The current therapeutic strategies for targeting stem cell self-renewal pathways therefore...
4.
Lee T, Castilho A, Ma S, Ng I
Liver Int
. 2009 Jun;
29(7):955-65.
PMID: 19490415
Hepatocellular carcinoma (HCC) is an aggressive tumour with a poor prognosis. Current therapeutic strategies against this disease target mostly rapidly growing differentiated tumour cells. However, the result is often dismal...